CTLA4 and neoplasm: By tumor weight analysis at day 25, significant inhibition could be detected in comparison with the rAd.sT.GM + anti-CTLA-4 treatment to the untreated, rAd.sT.GM, anti-PD-1, and anti-CTLA-4, respectively.